A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients
Thromboembolic (TE) complications [myocardial infarction (MI), stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE)] are common causes of mortality in hospitalised COVID-19 patients. Therefore, this review was undertaken to explore the incidence of TE complications and mortality associate...
Published in: | BMC INFECTIOUS DISEASES |
---|---|
Main Authors: | , , , , , |
Format: | Review |
Language: | English |
Published: |
BMC
2024
|
Subjects: | |
Online Access: | https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001218483400002 |
author |
Othman Hanies Yuhana; Zaki Izzati Abdul Halim; Isa Mohamad Rodi; Ming Long Chiau; Zulkifly Hanis Hanum |
---|---|
spellingShingle |
Othman Hanies Yuhana; Zaki Izzati Abdul Halim; Isa Mohamad Rodi; Ming Long Chiau; Zulkifly Hanis Hanum A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients Infectious Diseases |
author_facet |
Othman Hanies Yuhana; Zaki Izzati Abdul Halim; Isa Mohamad Rodi; Ming Long Chiau; Zulkifly Hanis Hanum |
author_sort |
Othman |
spelling |
Othman, Hanies Yuhana; Zaki, Izzati Abdul Halim; Isa, Mohamad Rodi; Ming, Long Chiau; Zulkifly, Hanis Hanum A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients BMC INFECTIOUS DISEASES English Review Thromboembolic (TE) complications [myocardial infarction (MI), stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE)] are common causes of mortality in hospitalised COVID-19 patients. Therefore, this review was undertaken to explore the incidence of TE complications and mortality associated with TE complications in hospitalised COVID-19 patients from different studies. A literature search was performed using ScienceDirect and PubMed databases using the MeSH term search strategy of COVID-19, thromboembolic complication, venous thromboembolism, arterial thromboembolism, deep vein thrombosis, pulmonary embolism, myocardial infarction, stroke, and mortality. There were 33 studies included in this review. Studies have revealed that COVID-19 patients tend to develop venous thromboembolism (PE:1.0-40.0% and DVT:0.4-84%) compared to arterial thromboembolism (stroke:0.5-15.2% and MI:0.8-8.7%). Lastly, the all-cause mortality of COVID-19 patients ranged from 4.8 to 63%, whereas the incidence of mortality associated with TE complications was between 5% and 48%. A wide range of incidences of TE complications and mortality associated with TE complications can be seen among hospitalized COVID-19 patients. Therefore, every patient should be assessed for the risk of thromboembolic complications and provided with an appropriate thromboprophylaxis management plan tailored to their individual needs. BMC 1471-2334 2024 24 1 10.1186/s12879-024-09374-1 Infectious Diseases gold WOS:001218483400002 https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001218483400002 |
title |
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients |
title_short |
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients |
title_full |
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients |
title_fullStr |
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients |
title_full_unstemmed |
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients |
title_sort |
A systematic review of thromboembolic complications and outcomes in hospitalised COVID-19 patients |
container_title |
BMC INFECTIOUS DISEASES |
language |
English |
format |
Review |
description |
Thromboembolic (TE) complications [myocardial infarction (MI), stroke, deep vein thrombosis (DVT), and pulmonary embolism (PE)] are common causes of mortality in hospitalised COVID-19 patients. Therefore, this review was undertaken to explore the incidence of TE complications and mortality associated with TE complications in hospitalised COVID-19 patients from different studies. A literature search was performed using ScienceDirect and PubMed databases using the MeSH term search strategy of COVID-19, thromboembolic complication, venous thromboembolism, arterial thromboembolism, deep vein thrombosis, pulmonary embolism, myocardial infarction, stroke, and mortality. There were 33 studies included in this review. Studies have revealed that COVID-19 patients tend to develop venous thromboembolism (PE:1.0-40.0% and DVT:0.4-84%) compared to arterial thromboembolism (stroke:0.5-15.2% and MI:0.8-8.7%). Lastly, the all-cause mortality of COVID-19 patients ranged from 4.8 to 63%, whereas the incidence of mortality associated with TE complications was between 5% and 48%. A wide range of incidences of TE complications and mortality associated with TE complications can be seen among hospitalized COVID-19 patients. Therefore, every patient should be assessed for the risk of thromboembolic complications and provided with an appropriate thromboprophylaxis management plan tailored to their individual needs. |
publisher |
BMC |
issn |
1471-2334 |
publishDate |
2024 |
container_volume |
24 |
container_issue |
1 |
doi_str_mv |
10.1186/s12879-024-09374-1 |
topic |
Infectious Diseases |
topic_facet |
Infectious Diseases |
accesstype |
gold |
id |
WOS:001218483400002 |
url |
https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001218483400002 |
record_format |
wos |
collection |
Web of Science (WoS) |
_version_ |
1809679004788064256 |